Improving and Accelerating Therapeutic Development for Nervous System Disorders
Publisher: National Academies Press 2013
Number of pages: 116
The aim was to examine opportunities to accelerate early phases of drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials, explored how new and emerging tools and technologies may improve the efficiency of research, and considered mechanisms to facilitate a more effective and efficient development pipeline.
Home page url
Download or read it online for free here:
by Holger Stark - De Gruyter Open Ltd
The histamine H4 receptor is the most recently detected histamine receptor subtype. The molecular signaling mechanism and localization of the receptor will be described together with its influence on physiological and pathophysiological properties.
by Wendy L Bennett, et al. - AHRQ
Given the number of medications available for type 2 diabetes mellitus, clinicians and patients need information about their effectiveness to make informed choices. The objective of this review was to summarize the benefits and harms of medications.
by J. Eric McDuffie (ed.) - InTech
Because the incidence of neurobehavioral hazards and risks of exogenous compounds remain subject matter of interest, predictive tools have evolved, including novel translational in vitro models, biomarkers, newer epidemiological research tools, etc.
- World Health Organization
Clinical Pharmacology is the scientific discipline that involves all aspects of the relationship between drugs and humans. It is a multidisciplinary science that encompasses professionals with a wide variety of scientific skills.